## **Core Concept**
Thyroid cancers are classified into several types, including papillary, follicular, medullary, and anaplastic. Among these, the metastatic potential and common sites of metastasis vary. Bone metastasis is a significant concern in certain types of thyroid cancer.

## **Why the Correct Answer is Right**
Follicular thyroid carcinoma (FTC) is known for its tendency to metastasize hematogenously, which means it commonly spreads through the bloodstream. This hematogenous spread frequently leads to metastasis in distant sites, including the bones. The follicular type accounts for a smaller proportion of thyroid cancers but has a higher rate of distant metastasis compared to papillary thyroid cancer. The bones, lungs, and liver are common sites for follicular thyroid cancer metastasis.

## **Why Each Wrong Option is Incorrect**
- **Option A (Papillary thyroid carcinoma):** While papillary thyroid carcinoma (PTC) can metastasize to lymph nodes and distant sites, it more commonly spreads to lymph nodes rather than directly to bones.
- **Option C (Medullary thyroid carcinoma):** Medullary thyroid carcinoma (MTC) originates from parafollicular cells (C cells) and can spread to lymph nodes and distant sites. However, it is less commonly associated with bone metastasis compared to follicular thyroid carcinoma.
- **Option D (Anaplastic thyroid carcinoma):** Anaplastic thyroid carcinoma is a highly aggressive and rare form of thyroid cancer. It grows rapidly and often spreads locally and to distant sites. While it can metastasize to bones, its overall prognosis is poor due to rapid growth and local invasion, making bone metastasis less characteristic as a hallmark compared to follicular carcinoma.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that follicular thyroid carcinoma has a predilection for hematogenous spread, making bone, lung, and liver common sites for metastasis. This pattern helps in the diagnostic workup and management planning for patients with thyroid cancer.

## **Correct Answer:** . Follicular thyroid carcinoma.